Phibro Animal Health Corporation (PAHC) - News Archive

Showing 4 of 4 results.

Phibro Animal Health Corporation Declares Increased Dividend Amid Strong Stock Performance, Signaling Confidence and Growth

TEANECK, N.J. In a recent announcement that resonates positively with investors, the Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) declared a quarterly cash dividend of $0.12 per share on both it...

Jul 31, 2024 • Major Pharmaceutical Preparations Industry Dividend Nasdaq

Phibro Animal Health Corporation Continues to Advance Animal Health, Nutrition, and Sustainability with Annual ESG Re...

In a recent press release, Phibro Animal Health Corporation proudly announced the release of its third annual Environmental, Social, and Governance (ESG) Report, showcasing the company s accomplishments in 2023. Recogni...

Jun 6, 2024 • Major Pharmaceutical Preparations Industry Business Update Nasdaq

Connecting Lives for a Sustainable Future: Phibro Animal Health Corporations Journey towards ESG Excellence ...

Phibro Animal Health Corporation s Third Annual ESG Report Highlights Commitment to Animal Health, Nutrition, and SustainabilityPhibro Animal Health Corporation, a leading provider of animal health and nutrition solutio...

Jun 5, 2024 • Major Pharmaceutical Preparations Industry Business Update Nasdaq

Zoetis, headquartered in Parsippany, New Jersey, is known for its wide range of innovative animal health solutions. Their MFA product portfolio includes additives that are mixed with animal feed to enhance nutrition, prevent diseases, and promote growth. However, as part of their ongoing business strategy, Zoetis has decided to divest this particular segment and focus on their core areas of expe...

Zoetis, a leading animal health company, recently announced its decision to sell its medicated feed additive (MFA) product portfolio to Phibro Animal Health Corporation in a definitive agreement worth $350 million. The...

Apr 29, 2024 • Major Pharmaceutical Preparations Industry Business Update Nasdaq